key: cord-0921027-kcq2dsp3 authors: Perna, Andrea; Passiatore, Marco; Massaro, Antonio; Terrinoni, Alessandro; Bianchi, Luca; Cilli, Vitale; D’Orio, Marco; Proietti, Luca; Taccardo, Giuseppe; De Vitis, Rocco title: Skin manifestations in COVID‐19 patients, state of the art. A systematic review date: 2021-02-02 journal: Int J Dermatol DOI: 10.1111/ijd.15414 sha: 14ce64f3efc5f9b8d42ab5be15cd3545799745a0 doc_id: 921027 cord_uid: kcq2dsp3 INTRODUCTION: Since COVID‐19 has become a pandemic, extensive literature has been produced. The commonest symptoms of COVID‐19 disease are fever, cough, anosmia, and lymphocytopenia. However, other apparently less common clinical symptoms have been described, including skin lesions. We conducted a systematic review to evaluate skin involvement in COVID‐19. METHODS: The authors performed a systematic review of literature, in accordance with the Preferred Reporting Items for Systematic and Meta‐Analysis (PRISMA). The search was reiterated until May 06, 2020. RESULTS: Overall, 1593 patients (M/F ratio: 1 : 9) with suspect of COVID‐19 were examined. The mean age was 37.8 (range 0–91) years. Among the analyzed patients, 84 (5.3%) were pediatrics (<18 years). Chilblains are very common among skin lesions and represent almost half of all skin lesions reported (46%); in 75% of patients with cutaneous manifestation, the latter presented before other typical clinical manifestation of COVID‐19. Vasculitis or thrombosis was identified in almost 70% of patients who suffered from skin manifestations. CONCLUSION: The present study highlights the importance of skin involvement in COVID‐19. Limbs should be examined to eventually foresee the onset of further typical symptoms. Chilblains can be considered typical features. Studies with higher scientific evidence are required. Introduction SARS-CoV-2 became a pandemic in March 2020. 1 Many efforts were conducted by the researcher to clarify and classify the clinical manifestation of COVID-19 disease. 2, 3 The commonest symptoms of COVID-19 are fever, cough, anosmia, and lymphocytopenia. 3, 4 However, other less common clinical symptoms have been described. 3 Recently, clinicians have focused their attention on other signs of COVID-19. Skin manifestations are not uncommon in viral infections (viral exanthemas). [5] [6] [7] Hence, variable clinical skin manifestations were described in COVID-19. Different kinds of rash, chilblains, livedo reticularis, urticaria, purpura, and vasculitis were observed in COVID-19-positive patients. The role of skin manifestations, where present, in the clinical history of COVID-19 is still unclear. 5, 6, 8, 13, 20, 25, 32, 33, 36, 41, 46 The aim of the present study was to review the available literature data on skin manifestations related to COVID-19 and evaluate their epidemiology, possible clinical correlation, and prognostic factors. The present study is a systematic literature review reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Fig. 1) . 48 The review questions were formulated following the PICO scheme (population, intervention, comparison, and outcome) as follows: • Did patients suffering from COVID-19 (P) report worse clinical outcomes (C) in terms of comorbidity and mortality (O) when cutaneous manifestation occurred (I)? • Were the clinical outcomes (O) influenced by the type of lesions' pattern (I)? • Was the type of pattern (I) influenced by comorbidities (P)? In the present investigation, full-text articles were analyzed evaluating the correlation between the COVID-19 and the presence of skin lesions. Only articles written in English were included. No publication date limits were set. Exclusion criteria were: studies on animals, unpublished reports, cadaver or in vitro investigations, review of the literature, abstracts from scientific meetings, and book chapters. Search strategy and study selection MEDLINE via PubMed and Scopus were searched using the keywords: "SARS-CoV-2", "Covid 19", "Skin", "cutaneous", "dermatological", "rash", "dermatology", and their MeSH terms in any possible combination. The reference lists of relevant studies were forward searched to identify other studies of interest. The search was reiterated until May 06, 2020. Two independent reviewers (M.P. and A.M.) pulled out the data from the studies included. Any discordances were solved by consensus with a third author (A.P.). For each study, the following data were collected: demographic features, COVID-19 diagnosis, respiratory symptoms, type of skin lesions, treatment options, possible complications and outcomes, and follow-up. Numbers software (Apple Inc., Cupertino, CA, USA) was used to tabulate the collected data. Categorical variables are presented as frequency and percentages. Continuous variables are presented as means and standard deviation. Only one decimal digit was reported and was rounded up. After the screening of 298 articles by title and abstract, 57 studies were considered eligible for the full-text analysis. After exclusion of 14 studies, 43 studies that met inclusion criteria were included in the present review (Fig. 1) . Among the included studies, one had a level of evidence I, while 42 had a level of evidence IV. 49 Eleven of the included studies were conducted in Spain, 10 in Italy, eight in France, four in USA, three in China, two in Belgium, two in Iran, one in Germany, one in Kuwait, and one in Thailand. Table 2 . In 10 studies, the skin lesions were treated with pharmacological therapies. In seven patients, systemic antihistamines were administered until cutaneous manifestations disappeared, while in three cases topical steroids were prescribed. In the other This review showed that the clinical outcome of COVID-19 would not seem to be influenced by the presence of the skin lesions. However, Zang et al. 8 Manalo et al., 20 and Jimenez-Cahue et al. 46 argued that it could be a correlation between patients' comorbidities and type of skin lesions, caused by a mechanism of immunity downregulation. The (Table 2) . 31, 34, 39 These findings could play a determining role in the pathogenesis of COVID-19, shifting the attention from an organ disease to a systemic one; therefore, this topic should be further investigated. COVID-19 seems to be less serious during childhood, even though recent cases of Kawasaki disease in children were increasingly reported, and SARS-CoV-2 was suspected to be responsible for this increase. [51] [52] [53] [54] Being a systemic vasculitis, Lymphoid infiltrate, perivascular pattern, and signs of endothelial activation. Gianotti 2020 31 • Superficial perivascular dermatitis, lymphocytic exocytosis. Swollen thrombosed vessels with neutrophils, eosinophils, and nuclear debris in the dermis. • Superficial and deep perivascular dermatitis, lymphocytes surrounding blood vessels in a vasculitic pattern. Extravasated red blood cells from damaged vessels. • Acantholytic suprabasal clefts, dyskeratotic and ballooning herpes-like keratinocytes. Lymphocytic satellitosis, dense lymphocyte infiltration, eosinophils, Langerhans cells. Zengarini 2020 6 Perivascular lymphocytic infiltrate, extremely dilated vessel in dermis. Marzano 2020 19 Atrophic epidermis and vacuolar degeneration of the basal layer. Dyskeratotic cells. Vacuolar alteration. Sanchez 2020 12 Spongiosis with focal parakeratosis in the epidermis. Aggregates of lymphocytes and Langerhans cells. Magro 2020 7 • Significant vascular deposits of C5b-9 within dermal capillaries. • Thrombogenic vasculopathy, extensive necrosis of the epidermis and adnexal structures, perivascular neutrophilia, deposition of C5b-9. • Vascular ectasia, vascular deposits of C5b-9, C3d, and C4d, occluded artery. • Perivascular lymphocytic, deeper seated small thrombi, significant vascular deposits of C5b-9 and C4d. Fernandez-Nieto 2020 34 Perivascular infiltrate of lymphocytes, some eosinophils and upper dermal edema Kolivras 2020 25 Lichenoid, perivascular, and perieccrine infiltrate of lymphocytes. The basement membrane zone was smudged, and there was papillary dermal fibrin confined near the ulcer edge. The infiltrate was dense and lichenoid in the papillary and superficial reticular dermis. The venules surrounded by the lymphoplasmacytic infiltrate had plump endothelial cells. No intraluminal fibrin thrombi. Ahouach 2020 45 Light spongiosis, basal cell vacuolation, and mild perivascular lymphocytic infiltrate. Diaz-Guimaraens 2020 39 Perivascular lymphocytic infiltrate with abundant red cell extravasation, focal papillary edema, focal parakeratosis, and isolated dyskeratotic cells. No intraluminal fibrin thrombi. International Journal of Dermatology 2021 ª 2021 the International Society of Dermatology Kawasaki disease may cause skin lesions and should be considered in further literature. 51, 53, 54 Additional investigations about skin vasculitis in SARS-CoV-2 are needed. 51, 53, 54 Nevertheless, according to our results, low-quality evidence studies were produced in case reports and case series (level IV) with insufficient and/or unclear data. Therefore, it was not possible to answer the above-mentioned review questions. however, this did not preclude the use of these helpful data. 50 Because of the novelty of this disease, another problem that confronted the authors was the nonuniformity of data. 58 Hence, we have only included studies where a clear diagnosis of the skin lesions was possible. Although certain biases were found, this review highlights the importance of skin involvement in COVID-19. Limbs should be carefully examined to eventually foresee the onset of further typical symptoms. Chilblains could be considered typical features of COVID-19. Studies with higher scientific evidence are required to validate our findings. Disaggregated data are welcome in order to improve knowledge. World Health Organization. WHO announces COVID-19 outbreak a pandemic Novel coronavirus: where we are and what we know Clinical Characteristics of Coronavirus Disease 2019 in China Isolated Sudden Onset Anosmia in COVID-19 Infection. A Novel Syndrome? Morbilliform exanthem associated with COVID-19 Histological pattern in Covid-19 induced viral rash Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Acral cutaneous lesions in the Time of COVID-19 Cutaneous manifestations in COVID-19: a first perspective Urticarial exanthem as early diagnostic clue for COVID-19 infection Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2) Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019) Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients A dermatologic manifestation of COVID-19: transient livedo reticularis A distinctive skin rash associated with coronavirus disease 2019? Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic Chilblainlike lesions on feet and hands during the COVID-19 Pandemic COVID-19) infection-induced chilblains: a case report with histopathologic findings Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report COVID-19 can present with a rash and be mistaken for dengue A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom Urticarial eruption in COVID-19 infection Comment on "Cutaneous manifestations in COVID-19: a first perspective Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: a diagnostic clue? Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies Characterization of acute acro-ischemic lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak Cutaneous manifestations in COVID-19: a new contribution Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Did Whatsapp(â) reveal a new cutaneous COVID-19 manifestation? Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Infants Born to Mothers With a New Coronavirus (COVID-19) Vascular skin symptoms in COVID-19: a french observational study Cutaneous manifestation of COVID-19 in images: a case report SARS-CoV-2 infection presenting as a febrile rash A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East Cutaneous lesions in a patient with COVID-19: are they related? the International Society of Dermatology Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Evidence-based medicine: what it is and what it is not The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 COVID-19 and Kawasaki Disease: Novel Virus and Novel Case Incomplete Kawasaki Disease in a Child with COVID-19 COVID-19 and Kawasaki syndrome: should we really be surprised? COVID-19 and Kawasaki Disease: Finding the Signal in the Noise Gender differences in COVID-19: the importance of sex-disaggregated data COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions? Spinal surgery in COVID-19 pandemic era: One trauma hub center experience in central-southern Italy Chilblain-like lesions on feet and hands during the COVID-19 pandemic The authors thank Dr. Eileen Mckendrick for English language editing assistance.